Results 111 to 120 of about 1,807 (174)

Evidence syntheses to support decision-making related to the Covid-19 pandemic. [PDF]

open access: yesRev Saude Publica
Andrade KRC   +14 more
europepmc   +1 more source

Comunicado de Seguridad de Farmacovigilancia Nº 11-2024. Hidroxicloroquina y retinopatía

open access: yes
La hidroxicloroquina (HCQ) es un medicamento que actúa modulando la actividad del sistema inmunológico, y es crucial en el tratamiento del lupus eritematoso sistémico y la artritis reumatoide.
Seguro Social de Salud (EsSalud). Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI). Dirección de Guías de Práctica Clínica, Farmacovigilancia y Tecnovigilancia. Centro de Referencia Institucional de Farmacovigilancia y Tecnovigilancia (CRI-EsSalud)
core  

[Hydroxychloroquine-induced erythema multiforme in a patient with COVID-19]. [PDF]

open access: yesMed Clin (Barc), 2020
Monte Serrano J   +3 more
europepmc   +2 more sources

[Heart transplant during the COVID-19 pandemic: follow-up organization and characteristics of infected patients]. [PDF]

open access: yesRev Esp Cardiol, 2020
García-Cosío MD   +5 more
europepmc   +1 more source

[Ischaemic stroke associated with COVID-19 in dialysis patients]. [PDF]

open access: yesNefrologia, 2021
de Lorenzo A   +6 more
europepmc   +1 more source

Whipple's Disease as a Differential Diagnosis of Blood Culture-Negative Endocarditis: A Case Report. [PDF]

open access: yesArq Bras Cardiol
Soares CK   +5 more
europepmc   +1 more source

[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review]. [PDF]

open access: yesNeurologia, 2020
Trujillo Gittermann LM   +2 more
europepmc   +1 more source

Do in vitro ao in vivo: a eficácia da cloroquina no tratamento da COVID-19

open access: yesJournal of Evidence-Based Healthcare, 2020
Filipe Mosca Guerra
doaj   +1 more source

Home - About - Disclaimer - Privacy